CLINICAL_TRIALS
trial_result
· 2023-02-16
Clinical Trial Update: Efficacy and Safety of Dual Therapy as First-line Treatment for Hp Infection [Phase 4]
Summary
Phase 4 trial update assessing efficacy and safety of dual therapy as first-line treatment for Helicobacter Pylori infection.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University | Conditions: Helicobacter Pylori Infection | Phase 4 | Status: UNKNOWN